By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Exonics Therapeutics 

745 Atlantic Avenue

Boston  Massachusetts  02111  U.S.A.
Phone: 857-288-1518 Fax: n/a


SEARCH JOBS

At Exonics Therapeutics, our mission is to permanently correct genetic mutations resulting in neuromuscular diseases like Duchenne muscular dystrophy. Duchenne is a devastating muscle disease in children, primarily boys, caused by the absence of dystrophin. Our approach utilizes gene editing technologies such as CRISPR/Cas9 to correct a majority of the genetic mutations in Duchenne, and enable dystrophin production.

YEAR FOUNDED:

February 2017

LEADERSHIP:

Scientific Founder and Chief Science Advisor Eric Olson, PhD.

President and CEO: Jak Knowles


Key Statistics


Email: info@exonicstx.com
Ownership: Private

Web Site: Exonics Therapeutics
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->